FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095180876> ?p ?o ?g. }

• W2095180876 endingPage "68" @default.
• W2095180876 startingPage "63" @default.
• W2095180876 abstract "The purpose of this study was to compare the antibody responses to varicella-zoster virus (VZV) gE and gB after natural VZV infection and after vaccination with live attenuated OKA vaccine in order to determine the relative importance of these proteins as components of a subunit vaccine. Anti-VZV antibody titers determined by IFA were of the same order of magnitude in sera from individuals with a history of varicella and in vaccinated children but higher in individuals given booster vaccination. The titers of anti-gE and anti-gB antibodies were measured by ELISA using recombinant gE or gB as capture antigen. From these experiments, it appears that the ratio of anti-gE to anti-gB antibody is highly variable from one individual to another but relatively stable over a long period of time for a particular individual, even after a zoster episode. Neutralizing antibodies directed against gE or gB were also measured by subtracting the neutralization titers obtained before and after depletion of the specific antibodies on immobilized recombinant gE, gB, or both. This showed that, with respect to neutralization, anti-gE and anti-gB are equally prevalent in vaccinated children and that anti-gE is generally, but not always, predominant over anti-gB in VZV-infected individuals. Finally, antibodies to these two glycoproteins appear to be predominant among the neutralizing antibodies directed to other VZV antigens." @default.
• W2095180876 created "2016-06-24" @default.
• W2095180876 creator A5004733066 @default.
• W2095180876 creator A5014375309 @default.
• W2095180876 creator A5021500041 @default.
• W2095180876 creator A5045544889 @default.
• W2095180876 creator A5056722818 @default.
• W2095180876 creator A5059505621 @default.
• W2095180876 creator A5059879385 @default.
• W2095180876 creator A5059991952 @default.
• W2095180876 creator A5078031037 @default.
• W2095180876 creator A5081867970 @default.
• W2095180876 creator A5082147359 @default.
• W2095180876 date "1997-09-01" @default.
• W2095180876 modified "2023-09-25" @default.
• W2095180876 title "Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization" @default.
• W2095180876 cites W1996764255 @default.
• W2095180876 cites W2018049270 @default.
• W2095180876 cites W2027395196 @default.
• W2095180876 cites W2033432694 @default.
• W2095180876 cites W2037199854 @default.
• W2095180876 cites W2046013402 @default.
• W2095180876 cites W2059956338 @default.
• W2095180876 cites W2063466305 @default.
• W2095180876 cites W2073960201 @default.
• W2095180876 cites W2081089869 @default.
• W2095180876 cites W2081527399 @default.
• W2095180876 cites W2092264542 @default.
• W2095180876 cites W2105887133 @default.
• W2095180876 cites W2109290291 @default.
• W2095180876 cites W2131570574 @default.
• W2095180876 cites W2140898723 @default.
• W2095180876 cites W2323197498 @default.
• W2095180876 cites W2325611695 @default.
• W2095180876 doi "https://doi.org/10.1002/(sici)1096-9071(199709)53:1<63::aid-jmv11>3.0.co;2-y" @default.
• W2095180876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9298734" @default.
• W2095180876 hasPublicationYear "1997" @default.
• W2095180876 type Work @default.
• W2095180876 sameAs 2095180876 @default.
• W2095180876 citedByCount "21" @default.
• W2095180876 countsByYear W20951808762012 @default.
• W2095180876 countsByYear W20951808762013 @default.
• W2095180876 countsByYear W20951808762014 @default.
• W2095180876 countsByYear W20951808762016 @default.
• W2095180876 countsByYear W20951808762018 @default.
• W2095180876 countsByYear W20951808762019 @default.
• W2095180876 countsByYear W20951808762021 @default.
• W2095180876 countsByYear W20951808762022 @default.
• W2095180876 countsByYear W20951808762023 @default.
• W2095180876 crossrefType "journal-article" @default.
• W2095180876 hasAuthorship W2095180876A5004733066 @default.
• W2095180876 hasAuthorship W2095180876A5014375309 @default.
• W2095180876 hasAuthorship W2095180876A5021500041 @default.
• W2095180876 hasAuthorship W2095180876A5045544889 @default.
• W2095180876 hasAuthorship W2095180876A5056722818 @default.
• W2095180876 hasAuthorship W2095180876A5059505621 @default.
• W2095180876 hasAuthorship W2095180876A5059879385 @default.
• W2095180876 hasAuthorship W2095180876A5059991952 @default.
• W2095180876 hasAuthorship W2095180876A5078031037 @default.
• W2095180876 hasAuthorship W2095180876A5081867970 @default.
• W2095180876 hasAuthorship W2095180876A5082147359 @default.
• W2095180876 hasConcept C14086860 @default.
• W2095180876 hasConcept C147483822 @default.
• W2095180876 hasConcept C159047783 @default.
• W2095180876 hasConcept C159654299 @default.
• W2095180876 hasConcept C203014093 @default.
• W2095180876 hasConcept C22070199 @default.
• W2095180876 hasConcept C22889606 @default.
• W2095180876 hasConcept C2522874641 @default.
• W2095180876 hasConcept C2776159415 @default.
• W2095180876 hasConcept C2779261636 @default.
• W2095180876 hasConcept C2780473352 @default.
• W2095180876 hasConcept C2780801004 @default.
• W2095180876 hasConcept C32611913 @default.
• W2095180876 hasConcept C71924100 @default.
• W2095180876 hasConcept C86803240 @default.
• W2095180876 hasConceptScore W2095180876C14086860 @default.
• W2095180876 hasConceptScore W2095180876C147483822 @default.
• W2095180876 hasConceptScore W2095180876C159047783 @default.
• W2095180876 hasConceptScore W2095180876C159654299 @default.
• W2095180876 hasConceptScore W2095180876C203014093 @default.
• W2095180876 hasConceptScore W2095180876C22070199 @default.
• W2095180876 hasConceptScore W2095180876C22889606 @default.
• W2095180876 hasConceptScore W2095180876C2522874641 @default.
• W2095180876 hasConceptScore W2095180876C2776159415 @default.
• W2095180876 hasConceptScore W2095180876C2779261636 @default.
• W2095180876 hasConceptScore W2095180876C2780473352 @default.
• W2095180876 hasConceptScore W2095180876C2780801004 @default.
• W2095180876 hasConceptScore W2095180876C32611913 @default.
• W2095180876 hasConceptScore W2095180876C71924100 @default.
• W2095180876 hasConceptScore W2095180876C86803240 @default.
• W2095180876 hasIssue "1" @default.
• W2095180876 hasLocation W20951808761 @default.
• W2095180876 hasLocation W20951808762 @default.
• W2095180876 hasOpenAccess W2095180876 @default.
• W2095180876 hasPrimaryLocation W20951808761 @default.
• W2095180876 hasRelatedWork W120339149 @default.
• W2095180876 hasRelatedWork W1569370738 @default.

• next